The Vanguard Group Discloses Position in Mural Oncology

The Vanguard Group, Inc. has disclosed its position concerning Mural Oncology plc under the Irish Takeover Panel's Rule 8.3. As of June 12, 2025, Vanguard holds interests in 4.48% of Mural Oncology's $0.01 ordinary shares, totaling 773,027 shares. No cash-settled or stock-settled derivatives have been reported.

The transaction details include the purchase of 32 ordinary shares at $2.53 each and the sale of 64 shares at the same price. No additional dealings such as subscriptions or conversions have occurred. Furthermore, Vanguard reports no indemnity, option arrangements, or any agreements that might entice dealings, reflecting a straightforward disclosure.

In conclusion, Vanguard's interest in Mural Oncology's securities suggests an influential stake, yet no complex financial instruments or strategies appear involved in this case.